U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C5H5N5.H3O4P
Molecular Weight 233.1219
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ADENINE PHOSPHATE

SMILES

OP(O)(O)=O.NC1=C2N=CNC2=NC=N1

InChI

InChIKey=CCHNOBQMQBSRHQ-UHFFFAOYSA-N
InChI=1S/C5H5N5.H3O4P/c6-4-3-5(9-1-7-3)10-2-8-4;1-5(2,3)4/h1-2H,(H3,6,7,8,9,10);(H3,1,2,3,4)

HIDE SMILES / InChI

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/25797921 | https://www.ncbi.nlm.nih.gov/pubmed/9046330 | https://www.ncbi.nlm.nih.gov/pubmed/2165159 | https://www.ncbi.nlm.nih.gov/pubmed/27776394 | https://www.ncbi.nlm.nih.gov/pubmed/26243842

Adenine is a nucleobase (a purine derivative). Its derivatives have a variety of roles in biochemistry including cellular respiration, in the form of both the energy-rich adenosine triphosphate (ATP) and the cofactors nicotinamide adenine dinucleotide (NAD) and flavin adenine dinucleotide (FAD). It also has functions in protein synthesis and as a chemical component of DNA and RNA. The shape of adenine is complementary to either thymine in DNA or uracil in RNA

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
85.8 µM [Ki]
200.0 µM [IC50]
10.89 µM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
LEUKOTRAP WB SYSTEM

Approved Use

Indicated for collection of blood and preparation of red blood cells and plasma with pre-storage leukocyte reduction. Platelet concentrates are not intended to be made with this product.
Secondary
Unknown

Approved Use

Unknown
Secondary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Adenine-induced selective apoptosis toward HIV chronically infected cells in vitro.
2000 Jul 14
Influence of a probiotic yoghurt on the status of vitamins B(1), B(2) and B(6) in the healthy adult human.
2001
A novel polymorphism (-88 C>A) in the 5' UTR of the p53R2 gene.
2001
Molecular characterization of monoamine oxidases A and B.
2001
Cloning of dimethylglycine dehydrogenase and a new human inborn error of metabolism, dimethylglycine dehydrogenase deficiency.
2001 Apr
Quantum-chemical analysis of C-H...O and C-H...N interactions in RNA base pairs--H-bond versus anti-H-bond pattern.
2001 Feb
Mechanisms and modulation of intestinal epithelial repair.
2001 Feb
NO Inhibits NaCl absorption by rat thick ascending limb through activation of cGMP-stimulated phosphodiesterase.
2001 Feb
De novo mutation in the mitochondrial tRNALeu(UUR) gene (A3243G) with rapid segregation resulting in MELAS in the offspring.
2001 Feb
Apoptosis induction by the photosensitizer verteporfin: identification of mitochondrial adenine nucleotide translocator as a critical target.
2001 Feb 15
"Chemical preconditioning" by 3-nitropropionate reduces ischemia-reperfusion injury in cardiac-arrested rat lungs.
2001 Feb 15
In situ kinetic characterization of methylthioadenosine transport by the adenosine transporter (P2) of the African Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense.
2001 Feb 15
FRET analysis indicates that the two ATPase active sites of the P-glycoprotein multidrug transporter are closely associated.
2001 Feb 6
Shiga toxin 1: damage to DNA in vitro.
2001 Feb-Mar
Activity of adenosine diphosphates and triphosphates on a P2Y(T) -type receptor in brain capillary endothelial cells.
2001 Jan
The structure of the chloroplast F1-ATPase at 3.2 A resolution.
2001 Jan 12
A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles.
2001 Jan 15
Oxidation of pyridine nucleotides during Fas- and ceramide-induced apoptosis in Jurkat cells: correlation with changes in mitochondria, glutathione depletion, intracellular acidification and caspase 3 activation.
2001 Jan 15
2-Alkynyl-8-aryl-9-methyladenines as novel adenosine receptor antagonists: their synthesis and structure-activity relationships toward hepatic glucose production induced via agonism of the A(2B) receptor.
2001 Jan 18
Selectively suppressed Ca2+-induced Ca2+ release activity of alpha-ryanodine receptor (alpha-RyR) in frog skeletal muscle sarcoplasmic reticulum: potential distinct modes in Ca2+ release between alpha- and beta-RyR.
2001 Jan 26
Conformation and dynamics of abasic sites in DNA investigated by time-resolved fluorescence of 2-aminopurine.
2001 Jan 30
Probing structure and dynamics of DNA with 2-aminopurine: effects of local environment on fluorescence.
2001 Jan 30
Development of virus-specific immune responses in SHIV(KU)-infected macaques treated with PMPA.
2001 Jan 5
Endonuclease V of Escherichia coli prevents mutations from nitrosative deamination during nitrate/nitrite respiration.
2001 Jan 5
Escherichia coli FtsH (HflB) degrades a membrane-associated TolAI-II-beta-lactamase fusion protein under highly denaturing conditions.
2001 Mar
cAMP-independent phosphorylation activation of CFTR by G proteins in native human sweat duct.
2001 Mar
Efficiency comparisons of rank and permutation tests based on summary statistics computed from repeated measures data.
2001 Mar 15
A(1) or A(3) adenosine receptors induce late preconditioning against infarction in conscious rabbits by different mechanisms.
2001 Mar 16
Expression and mutagenesis of the NqrC subunit of the NQR respiratory Na(+) pump from Vibrio cholerae with covalently attached FMN.
2001 Mar 9
Solution structure of an A-tract DNA bend.
2001 Mar 9
Molecular mechanism for functional interaction between DnaA protein and acidic phospholipids: identification of important amino acids.
2001 Mar 9
Patents

Sample Use Guides

the daily dose of adenine is 10-60 mg/day
Route of Administration: Oral
NIH/3T3 cells were plated at a density of 2 × 106 cells and left untreated overnight, cultural media was exchanged and experimental plates were exposed to adenine (200 -1200 mkM) for 24 hr. Cells were counted at various concentration of adenine or AICAR with a hemocytometer after diluting the sample 1:1 with 0.4% trypan blue solution (Sigma-Aldrich, St. Louis, MO, USA). Alternatively, the cell cytotoxicity of the cells was monitored with XTT assay. 50 μL of XTT reagent was added and the plates were then incubated for 4 hr at 37 °C in the dark. The absorbance at 490 nm with a reference wavelength set at 690 nm using VersaMax ELISA microplate reader
Name Type Language
ADENINE PHOSPHATE
Common Name English
ADENINE PHOSPHATE SALT
Common Name English
Adenine phosphate [WHO-DD]
Common Name English
1H-PURIN-6-AMINE, PHOSPHATE (1:1)
Systematic Name English
Code System Code Type Description
SMS_ID
100000086053
Created by admin on Sat Dec 16 18:02:09 GMT 2023 , Edited by admin on Sat Dec 16 18:02:09 GMT 2023
PRIMARY
CAS
70700-30-0
Created by admin on Sat Dec 16 18:02:09 GMT 2023 , Edited by admin on Sat Dec 16 18:02:09 GMT 2023
PRIMARY
FDA UNII
RUT8S5GS8Z
Created by admin on Sat Dec 16 18:02:09 GMT 2023 , Edited by admin on Sat Dec 16 18:02:09 GMT 2023
PRIMARY
PUBCHEM
198277
Created by admin on Sat Dec 16 18:02:09 GMT 2023 , Edited by admin on Sat Dec 16 18:02:09 GMT 2023
PRIMARY